Crossmark

IgG levels in Kawasaki disease and its association with clinical outcomes

Crossref DOI link: https://doi.org/10.1007/s10067-018-4339-0

Published Online: 2018-10-20

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yamazaki-Nakashimada, Marco Antonio

Gámez-González, Luisa Berenise

Murata, Chiharu

Honda, Takafumi

Yasukawa, Kumi

Hamada, Hiromichi
License Information

Text and Data Mining valid from 2018-10-20
More Information

Article History

Received: 8 May 2018

Revised: 30 September 2018

Accepted: 12 October 2018

First Online: 20 October 2018

Compliance with ethical standards

:

: Dr. Marco Yamazaki-Nakashimada declares having received lecture fees from Octapharma, CSL Behring and Shire; the other authors declare not having any conflict of interest.